235 related articles for article (PubMed ID: 10737274)
1. Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.
Weitz JI; Bates SM
Arch Intern Med; 2000 Mar; 160(6):749-58. PubMed ID: 10737274
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction.
Ferrario M; Merlini PA; Lucreziotti S; Poli A; Cantù F; Gobbi G; Bramucci E; Mussini A; Ardissino D
Int J Cardiol; 1999 Apr; 68 Suppl 1():S63-71. PubMed ID: 10328613
[TBL] [Abstract][Full Text] [Related]
3. [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
Auer J; Berent R; Maurer E; Mayr H; Weber T; Eber B
Herz; 2001 Mar; 26(2):99-110. PubMed ID: 11349620
[TBL] [Abstract][Full Text] [Related]
4. [Optimal platelet inhibition therapy in unstable angina pectoris and after coronary interventions].
Niessner A; Niessner H; Huber K
Herz; 2001 Apr; 26 Suppl 1():36-41. PubMed ID: 11349625
[TBL] [Abstract][Full Text] [Related]
5. New antiplatelet agents.
White HD; French JK; Ellis CJ
Aust N Z J Med; 1998 Aug; 28(4):558-64. PubMed ID: 9777140
[TBL] [Abstract][Full Text] [Related]
6. Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and back-Up Abciximab] Events Trial (CACHET).
Topol EJ
Am J Cardiol; 1998 Oct; 82(8B):63P-68P. PubMed ID: 9809894
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulants in acute coronary syndromes.
Turpie AG
Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
[TBL] [Abstract][Full Text] [Related]
9. New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.
O'Rourke RA; Hochman JS; Cohen MC; Lucore CL; Popma JJ; Cannon CP
Arch Intern Med; 2001 Mar; 161(5):674-82. PubMed ID: 11231699
[TBL] [Abstract][Full Text] [Related]
10. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
11. [Antithrombotic agents in unstable angina. Review of clinical trials].
Habis M; Morice MC
Ann Cardiol Angeiol (Paris); 1998 Jan; 47(1):22-31. PubMed ID: 9772929
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of acute coronary syndrome. Aspirin, heparin, low-molecular-weight heparin, hirudin and GP-IIb/IIIa blockers].
Gaede A; Terres W
Herz; 1999 Aug; 24(5):353-62. PubMed ID: 10505285
[TBL] [Abstract][Full Text] [Related]
13. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.
Montalescot G; Collet JP; Lison L; Choussat R; Ankri A; Vicaut E; Perlemuter K; Philippe F; Drobinski G; Thomas D
J Am Coll Cardiol; 2000 Jul; 36(1):110-4. PubMed ID: 10898421
[TBL] [Abstract][Full Text] [Related]
14. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network.
Circulation; 1998 Jun; 97(24):2386-95. PubMed ID: 9641689
[TBL] [Abstract][Full Text] [Related]
15. [New antithrombotic agents in coronary disease].
Montalescot G
Rev Med Interne; 1997; 18(6):450-9. PubMed ID: 9247044
[TBL] [Abstract][Full Text] [Related]
16. [Current therapy for unstable angina pectoris].
Burkhard-Meier C; Deutsch HJ; Erdmann E
Dtsch Med Wochenschr; 1999 Jun; 124(23):733-9. PubMed ID: 10396308
[No Abstract] [Full Text] [Related]
17. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
Chesebro JH; Badimon JJ
N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
[No Abstract] [Full Text] [Related]
18. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
Zhao XQ; Théroux P; Snapinn SM; Sax FL
Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731
[TBL] [Abstract][Full Text] [Related]
19. Advances in antithrombotic therapy: novel agents.
Turpie AG; Weitz JI; Hirsh J
Thromb Haemost; 1995 Jul; 74(1):565-71. PubMed ID: 8578525
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
Bosch X; Marrugat J
Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
